This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Wu Chung-Hsiun: Innovator in Immunology
Introduction
Wu Chung-Hsiun is a notable inventor based in Taiwan. He has made significant contributions to the field of immunology, particularly in the development of compounds that target P-Selectin Glycoprotein Ligand 1 (PSGL-1). His work aims to control unwanted immune responses, which can be crucial in treating various medical conditions.
Latest Patents
Wu Chung-Hsiun holds a patent for "Modulators Of P-Selectin Glycoprotein Ligand 1." This invention involves compounds that bind to PSGL-1 on the surface of T cells or natural killer (NK) cells. These compounds can be utilized to induce T cell or NK cell depletion and apoptosis. The methods derived from this invention are particularly useful in managing autoimmune diseases, transplant rejection, and allergic diseases. He currently has 0 patents registered.
Career Highlights
Wu Chung-Hsiun is associated with Abgenomics Cooperatief U.a., where he continues to advance his research in immunology. His innovative approach to targeting immune responses has the potential to lead to significant breakthroughs in medical treatments.
Collaborations
Wu has collaborated with notable colleagues, including Lin Rong-Hwa and Hsu Pei-Ling. Their combined expertise contributes to the ongoing research and development in the field of immunology.
Conclusion
Wu Chung-Hsiun is a dedicated inventor whose work in immunology is paving the way for new therapeutic strategies. His contributions are vital in addressing complex immune-related conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile